The study thus suggests yet another unexpected avenue for the GLP-1 drugs.

Discover the top 11 websites to buy GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe, ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health Organization guidelines.

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

The recommended use of GLP-1 therapies, including tirzepatide (Zepbound), semaglutide (Wegovy), and liraglutide (Saxenda), for adults with obesity is "grounded in the recognition of obesity as a ...

The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide ...

The World Health Organization has issued its first-ever guidelines for the use of GLP-1 drugs to treat obesity. The WHO has classified obesity as a chronic disease and endorsed the use of these drugs ...

The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of weight-related complications. Citing strong evidence for significant weight loss and ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs known as GLP-1 receptor agonists, including Ozempic.

This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity ...

Experts say the official recommendation reemphasizes the game-changing ability of GLP-1 medications, but stress that diet and exercise are integral to an effective treatment plan for obesity. The ...

The World Health Organisation (WHO), in its first global guidelines on Glucagon-Like Peptide-1 (GLP-1) therapies for obesity, has said these drugs must be used alongside intensive behavioural ...